PT Kalbe Farma Tbk
OTC: PTKFY0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Other OTC
- Sector
- Healthcare
- Industry
- Drug Manufacturers - General
- CEO
- Bernadette Ruth Setiady
- Employees
- 12,835
- Headquarters
- Jakarta, Indonesia
- IPO year
- 2012
- Market cap
- $10.1M
- Website
- https://www.kalbe.co.id
Loading PTKFY…
Loading profile data…Frequently asked questions about PTKFY
What does PT Kalbe Farma Tbk (PTKFY) do?
PT Kalbe Farma Tbk is engaged in the development, distribution, and trading of pharmaceutical products. It operates through the following divisions: Prescription Pharmaceutical, Consumer Health, Nutritionals, and Distribution and Logistic. The Prescription Pharmaceutical division offers generic drugs, branded generics, and licensed drugs, which...
Where does PTKFY trade?
PT Kalbe Farma Tbk (PTKFY) trades on the Other OTC.
What sector is PTKFY in?
PT Kalbe Farma Tbk (PTKFY) operates in the Healthcare sector, specifically in the Drug Manufacturers - General industry.
Who is the CEO of PT Kalbe Farma Tbk?
Bernadette Ruth Setiady is the chief executive officer of PT Kalbe Farma Tbk (PTKFY).
Where is PT Kalbe Farma Tbk headquartered?
PT Kalbe Farma Tbk is headquartered in Indonesia.
Does PTKFY pay a dividend?
Yes — PT Kalbe Farma Tbk (PTKFY) paid a trailing twelve-month dividend of USD 0.22 per share. Frequency and ex-dividend dates are tracked on the dividends tab.
When did PTKFY go public?
PT Kalbe Farma Tbk (PTKFY) completed its initial public offering in 2012.